BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33227150)

  • 1. Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity.
    Peska E; Balki M; Maxwell C; Ye XY; Downey K; Carvalho JCA
    Anaesthesia; 2021 Jul; 76(7):918-923. PubMed ID: 33227150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin at Elective Cesarean Delivery: A Dose-Finding Study in Pregnant People With Twin Pregnancy.
    Peska E; Balki M; Pfeifer W; Maxwell C; Ye XY; Downey K; Carvalho JCA
    Anesth Analg; 2024 Apr; 138(4):814-820. PubMed ID: 36480452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbetocin at elective caesarean section: a sequential allocation trial to determine the minimum effective dose in obese women.
    Drew T; Balki M; Farine D; Ye XY; Downey K; Carvalho JCA
    Anaesthesia; 2020 Mar; 75(3):331-337. PubMed ID: 31867715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.
    Lavoie A; McCarthy RJ; Wong CA
    Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ED
    Qian XW; Drzymalski DM; Lv CC; Guo FH; Wang LY; Chen XZ
    BMC Pregnancy Childbirth; 2019 Dec; 20(1):6. PubMed ID: 31892352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin requirements at elective cesarean delivery: a dose-finding study.
    Carvalho JC; Balki M; Kingdom J; Windrim R
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1005-10. PubMed ID: 15516392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
    George RB; McKeen D; Chaplin AC; McLeod L
    Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbetocin at Cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose.
    Nguyen-Lu N; Carvalho JC; Farine D; Seaward G; Ye XY; Balki M
    Can J Anaesth; 2015 Aug; 62(8):866-74. PubMed ID: 25860126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial.
    Sheehan SR; Montgomery AA; Carey M; McAuliffe FM; Eogan M; Gleeson R; Geary M; Murphy DJ;
    BMJ; 2011 Aug; 343():d4661. PubMed ID: 21807773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
    McDonagh F; Carvalho JCA; Abdulla S; Cordovani D; Downey K; Ye XY; Farine D; Morais M; Balki M
    Anaesthesia; 2022 Aug; 77(8):892-900. PubMed ID: 35343585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
    Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
    King KJ; Douglas MJ; Unger W; Wong A; King RA
    Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
    Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
    Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.
    Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of different infusion rates of oxytocin for maintaining uterine tone during elective caesarean section: A randomised double blind trial.
    Mohta M; Chowdhury RB; Tyagi A; Agarwal R
    Anaesth Intensive Care; 2021 May; 49(3):183-189. PubMed ID: 33934618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol. ECSSIT - Elective Caesarean Section Syntocinon Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section.
    Murphy DJ; Carey M; Montgomery AA; Sheehan SR;
    BMC Pregnancy Childbirth; 2009 Aug; 9():36. PubMed ID: 19703279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
    Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
    Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
    Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
    Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbetocin at elective Cesarean delivery: a sequential allocation trial to determine the minimum effective dose.
    Khan M; Balki M; Ahmed I; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2014 Mar; 61(3):242-8. PubMed ID: 24281981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.